We are live on ! Find out more
ORGS

Orgenesis Inc. Common Stock
ORGS

Delisted

ORGS was delisted on the 18th of October, 2024.

Back to rankings

22 hedge funds and large institutions have $5.67M invested in Orgenesis Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $4.99M → $5.67M (+$675K)

15% less funds holding

Funds holding: 26 → 22 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

92% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 13

99% less call options, than puts

Call options by funds: $1K | Put options by funds: $73K

Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
13
Closed
5
Calls
$1K
Puts
$73K
Net Calls
-$72K
Net Calls Change
+$34K

Top Buyers

Rank Fund Capital Flow
1
KCM
Kennedy Capital Management
Missouri
+$59.3K
2
State Street
State Street
Massachusetts
+$18.7K

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$62K
2
VF
Virtu Financial
New York
-$60.1K
3
Citadel Advisors
Citadel Advisors
Florida
-$55.5K
4
TSS
Two Sigma Securities
New York
-$42K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$36K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.21M -$11.1K -366 -0.4%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$683K – – –
BlackRock
3
BlackRock
New York
$444K -$7.87K -259 -2%
State Street
4
State Street
Massachusetts
$308K +$18.7K +616 +7%
Renaissance Technologies
5
Renaissance Technologies
New York
$200K -$18.2K -600 -9%
RC
6
Ronit Capital
United Kingdom
$188K – – –
Northern Trust
7
Northern Trust
Illinois
$134K – – –
BHB
8
Bank Hapoalim BM
Israel
$111K – – –
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$87K -$304 -10 -0.4%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$82K -$608 -20 -0.8%
KCM
11
Kennedy Capital Management
Missouri
$68K +$59.3K +1,951 New
VF
12
Virtu Financial
New York
$45K -$60.1K -1,976 -60%
Millennium Management
13
Millennium Management
New York
$35K -$36K -1,184 -54%
Morgan Stanley
14
Morgan Stanley
New York
$26K -$61 -2 -0.3%
Barclays
15
Barclays
United Kingdom
$25K – – –
Bank of America
16
Bank of America
North Carolina
$13K -$1.31K -43 -10%
Simplex Trading
17
Simplex Trading
Illinois
$6K -$7.6K -250 -56%
TFGT
18
TS Financial Group (TSFG)
Illinois
$3K – – –
BNP Paribas Financial Markets
19
BNP Paribas Financial Markets
France
$309 -$851 -28 -76%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
– -$62K -2,176 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$55.5K -1,827 Closed
TSS
22
Two Sigma Securities
New York
– -$42K -1,469 Closed
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
– -$36K -1,240 Closed
UBS Group
24
UBS Group
Switzerland
– -$27K -921 Closed
TRCT
25
Tower Research Capital (TRC)
New York
– -$4.86K -160 -96%
1
2

ORGS Hedge Fund Activity: Q1 2022 in Review

22 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q1 2022, worth a combined $5.67M — up 14% from $4.99M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ORGS and 1 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 1 added.

The largest buyer was Kennedy Capital Management, opening a new position worth an estimated $59.3K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $62K sold.

  • 22 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q1 2022, down from 26 in Q4 2021.
  • Funds reported $5.67M of Orgenesis Inc. Common Stock stock for Q1 2022, up 14% quarter-over-quarter.
  • 1 fund opened new Orgenesis Inc. Common Stock positions in Q1 2022 and 5 closed out, a net change of -4 holders.
  • The largest Orgenesis Inc. Common Stock buyer in Q1 2022 was Kennedy Capital Management, an estimated $59.3K added.
  • The largest Orgenesis Inc. Common Stock seller in Q1 2022 was Acadian Asset Management, an estimated $62K sold.

Based on aggregated 13F filings for Q1 2022.